biomedicina slovenica

re="Clin Cancer Res" : 14

  1. Hu-Lieskovan Siwen; Bračko Matej; Velenik Vaneja
    EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients
    2011 ►
  2. de Haas T; Hasselt N; Troost D; Caron H; Popović M; Zadravec-Zaletel L; Grajkowska W; Perek M; Osterheld MC; Ellison D
    Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression
    2008 ►
  3. Rokavec Matjaž; Justenhoven Christina; Schroth Werner; Istrate Monica Adina; Haas Susanne; Fischer Hans-Peter; Vollmert Caren; Illig Thomas; Hamann Ute; Ko Yon-Dschun; Glavač Damjan; Brauch Hiltrud
    A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk
    2007 ►
  4. Mezzanzanica Delia; Fabbi Marina; Bagnoli Marina; Staurengo Samantha; Losa Marco; Balladore Emanuela; Alberti Paola; Lusa Lara; Ditto Antonino; Ferrini Silvano
    Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients
    2008 ►
  5. Clayton Richard N; Pfeifer Marija; Atkinson A Brew; Belchetz Paul; Wass John AH; Kyrodimou Effie; Vanderpump Mark; Simpson David; Bicknell John; Farrell William E
    Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins
    2000 ►
  6. Strojan Primož; Budihna Marjan; Šmid Lojze; Svetic Branka; Vrhovec Ivan; Kos Janko; Škrk Janez
    Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck
    2000 ►
  7. Kos Janko; Krašovec Marta; Cimerman Nina; Nielsen Hans Jorgen; Christense Ib Jarle; Bruenner Nils
    Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis
    2000 ►
  8. Sier Cornelis FM; Casetta Giovanni; Verheijen Jan H; Tizziani Alessandro; Agape Vittorio; Kos Janko; Blasi Francesco; Hanemaaijer Roeland
    Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers
    2000 ►
  9. Serša G; Štabuc B; Čemažar M; Miklavčič D; Rudolf Z
    Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients
    2000 ►
  10. Lah Tamara T; Čerček Miha; Blejec Andrej; Kos Janko; Gorodetsky Ella; Somers Robert; Daskal Ierachmiel
    Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators
    2000 ►
  11. Kos Janko; Nielsen Hans-Jorgen; Krašovec Marta; Christensen Ib Jarle; Cimerman Nina; Stephens Ross W; Bruenner Nils
    Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer
    1998 ►
  12. Strojnik Tadej; Kos Janko; Židanik Boris; Golouh Rastko; Lah Tamara
    Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors
    1999 ►
  13. Kos Janko; Štabuc Borut; Schweiger Ana; Krašovec Marta; Cimerman Nina; Kopitar-Jerala Nataša; Vrhovec Ivan
    Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients
    1997 ►
  14. Ledakis P; Tester WT; Rosenberg N; Romero-Fischmann D; Daskal I; Lah TT
    Cathepsins D, B, and L in malignant human lung tissue
    1996 ►

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko